• Melanie Nana and Catherine Nelson-Piercy.
• Guy's and St Thomas' NHS Foundation Trust, London, UK melanienana28@hotmail.com.
• Clin Med (Lond). 2021 Sep 1; 21 (5): e446e450e446-e450.

AbstractPregnant women with COVID-19 are less likely to be symptomatic than non-pregnant counterparts. Risk factors for severe disease include being overweight or obese, greater than 35 years old, and having pre-existing comorbidities. Those who develop severe disease have increased rates of admission to an intensive care unit, requiring invasive ventilation and pre-term birth.Pregnant and breastfeeding women with COVID-19 should be investigated as of outside pregnancy and should receive proven therapies (such as corticosteroids and tocilizumab) on a risk/benefit basis. Admitted women should receive multidisciplinary care with input from senior decision makers and early escalation where required. There are no safety concerns -surrounding the COVID-19 vaccination and fertility or pregnancy, and so it should be offered to women based on their age and clinical risk group, in line with non-pregnant women.© Royal College of Physicians 2021. All rights reserved.

14 keywords...

hide…